In vivo secretory potential and the effect of combination therapy with octreotide and cabergoline in patients with clinically non-functioning pituitary adenomas.

Source:http://linkedlifedata.com/resource/pubmed/id/11167922

Download in:

View as

General Info

PMID
11167922